Sareum Holdings (SAR) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Dec 2018 07:00 AM
RNS
AGM Statement
30 Nov 2018 11:17 AM
RNS
Amendment to Preclinical Efficacy Announcement
30 Nov 2018 07:45 AM
RNS
Preclinical Efficacy for Immunotherapy Combination
15 Nov 2018 10:24 AM
RNS
Preclinical Data for SRA737 in Ovarian Cancer
14 Nov 2018 07:00 AM
RNS
AGM NOTICE
13 Nov 2018 07:00 AM
RNS
Directorate Change
08 Nov 2018 12:28 PM
RNS
Sierra Oncology Q3 2018 Results
26 Oct 2018 07:00 AM
RNS
Completion of Placing
01 Oct 2018 07:00 AM
RNS
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
27 Sep 2018 01:03 PM
RNS
Notice of Results
26 Sep 2018 07:00 AM
RNS
TYK2/JAK1 selected for certain cancers
11 Sep 2018 07:00 AM
RNS
Pre-Close Trading Statement
10 Sep 2018 07:00 AM
RNS
Selection of TYK2/JAK1 for autoimmune diseases
09 Aug 2018 01:15 PM
RNS
Sareum notes Sierra Oncology Q2 2018 Results
11 Jul 2018 09:38 AM
RNS
Notification of PCA Shareholding
15 Jun 2018 07:00 AM
RNS
Advisers
31 May 2018 07:00 AM
RNS
Sareum regains rights to Aurora+FLT3 inhibitors
10 May 2018 12:21 PM
RNS
SRA737 trial update in Sierra Oncology Q1 Results
24 Apr 2018 07:00 AM
RNS
Sareum to Present at BioTrinity 2018 in London
17 Apr 2018 12:45 PM
RNS
AACR 2018 Update
15 Mar 2018 07:00 AM
RNS
Late-breaker abstract for SRA737 accepted for AACR
13 Mar 2018 07:00 AM
RNS
Interim Results
27 Feb 2018 12:50 PM
RNS
Sierra Oncology expands SRA737 development program
22 Feb 2018 07:00 AM
RNS
Preclinical synergy of sra737 and PARP inhibitor
13 Feb 2018 07:00 AM
RNS
Notice of Interim Results
20 Dec 2017 11:00 AM
RNS
Issue of Options
19 Dec 2017 07:00 AM
RNS
Patent Grants in Japan & China for TYK2 Inhibitors
14 Dec 2017 11:01 AM
RNS
Result of AGM
14 Dec 2017 07:00 AM
RNS
AGM Statement
20 Nov 2017 07:00 AM
RNS
Notice of AGM and Annual Report & Accounts
14 Nov 2017 12:05 PM
RNS
Placing
31 Oct 2017 07:00 AM
RNS
Sierra Reports Preclinical Data for Chk1 Inhibitor
19 Oct 2017 07:00 AM
RNS
Final Results
09 Oct 2017 12:00 PM
RNS
Sierra Oncology host KOL Meeting on 12 Oct in NY
18 Sep 2017 12:00 PM
RNS
Sierra Oncology to host call on Chk1 inhibitor
22 Aug 2017 07:00 AM
RNS
Pre-Close Trading Statement
19 Jun 2017 07:00 AM
RNS
Sareum to Present at the ICCS 2017
05 Jun 2017 12:13 PM
RNS
Chk1 Clinical Trials Update
31 May 2017 07:00 AM
RNS
Sierra Oncology Granted US and EU Patents
25 May 2017 07:00 AM
RNS
Sierra Oncology to Present at ASCO Annual Meeting
09 May 2017 07:00 AM
RNS
Sareum to Present at BioTrinity 2017
09 Mar 2017 07:00 AM
RNS
Director Shareholding
20 Feb 2017 07:00 AM
RNS
Half-year Results
09 Feb 2017 07:00 AM
RNS
Notice of Interim Results
09 Jan 2017 12:05 PM
RNS
Milestone Payment from Chk1 Licence Agreement
22 Dec 2016 09:47 AM
RNS
Result of General Meeting
15 Dec 2016 11:38 AM
RNS
Result of AGM
06 Dec 2016 07:00 AM
RNS
Directors' Remuneration & General Meeting
29 Nov 2016 07:00 AM
RNS
Sareum to Present at AACR-NCI-EORTC Conference
21 Nov 2016 07:00 AM
RNS
Notice of AGM
UK 100

Latest directors dealings